| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.045 | 0.4 |